These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16828096)

  • 1. Non-anti-D antibodies in red-cell alloimmunization.
    Lobo GA; Nardozza LM; Camano L
    Int J Gynaecol Obstet; 2006 Aug; 94(2):139-40. PubMed ID: 16828096
    [No Abstract]   [Full Text] [Related]  

  • 2. Consequences for fetus and neonate of maternal red cell allo-immunisation.
    Howard H; Martlew V; McFadyen I; Clarke C; Duguid J; Bromilow I; Eggington J
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F62-6. PubMed ID: 9536844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red Blood Cell Alloimmunization in the Pregnant Patient.
    Webb J; Delaney M
    Transfus Med Rev; 2018 Oct; 32(4):213-219. PubMed ID: 30097223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP; Schonewille H; Brand A; Haasnoot GW; Claas FH; Lindenburg IT; Lopriore E; Oepkes D; Roelen DL; Doxiadis II
    Transfusion; 2013 May; 53(5):939-47. PubMed ID: 22924899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allo-immunization against antigens from non-D blood groups. Value of detection].
    Mannessier L; Goudemand M; Delecour M
    Lille Med; 1980 Mar; 25(3):90-3. PubMed ID: 6768941
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. About diminished transport of maternal IgG (RhD alloimmunization) to the fetus.
    Grozdea J; Alie-Daram S; Vergnes H; Brisson-Lougarre A; Calot M; Martin J; Fournie A
    Vox Sang; 1995; 68(2):134-5. PubMed ID: 7605505
    [No Abstract]   [Full Text] [Related]  

  • 11. [Test for blood group incompatibility in pregnancy].
    Okubo M; Tate A; Maeda H; Suzuki M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():803-6. PubMed ID: 20942195
    [No Abstract]   [Full Text] [Related]  

  • 12. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and molecular analyses of a patient with anti-G and anti-D due to alloimmunisation during her pregnancy.
    Chen Q; Xiao J; Huang C; Li M; Yao G
    Blood Transfus; 2015 Jul; 13(3):533-4. PubMed ID: 25761315
    [No Abstract]   [Full Text] [Related]  

  • 14. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 15. Transfusion medicine illustrated: blocked D phenomenon.
    Moiz B; Salman M; Kamran N; Shamsuddin N
    Transfusion; 2008 Aug; 48(8):1545-6. PubMed ID: 18713103
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
    Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
    Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S; Stefanović V; Capkun V
    Transfusion; 2011 Jul; 51(7):1380-8. PubMed ID: 21214583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gel test and conventional tube test for antibody detection and titration in D-negative pregnant women: study from a tertiary-care hospital in North India.
    Thakur MK; Marwaha N; Kumar P; Saha SC; Thakral B; Sharma RR; Saluja K; Dhawan HK; Jain A
    Immunohematology; 2010; 26(4):174-7. PubMed ID: 22356454
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemolytic disease of the newborn due to maternal irregular antibodies.
    Lin-Chu M; Broadberry RE; Chyou SC; Hung HY; Shen EY; Hsu CH; Ho MY
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):645-8. PubMed ID: 3116152
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of hemolytic disease of the newborn caused by irregular antibodies].
    Mickley H
    Ugeskr Laeger; 1983 Jun; 145(23):1763-5. PubMed ID: 6410568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.